Rituximab for nivolumab plus ipilimumab-induced encephalitis in a small-cell lung cancer patient
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/28/9/2318/19709797/mdx252.pdf
Reference5 articles.
1. Nivolumab plus ipilimumab in advanced melanoma;Wolchok;N Engl J Med,2013
2. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma;Postow;N Engl J Med,2015
3. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;N Engl J Med,2015
4. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial;Antonia;Lancet Oncol,2016
5. Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer;Williams;JAMA Neurol,2016
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Using Combination therapy to overcome diverse challenges of Immune Checkpoint Inhibitors treatment;International Journal of Biological Sciences;2024
2. Autopsy case of meningoencephalitis induced by nivolumab and ipilimumab in a patient being treated for non-small cell lung cancer;Internal Medicine;2024
3. Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy;Advanced Science;2023-12-02
4. Toxicity Associated with Immune Checkpoint Inhibitors: Analysis of Immune-Related Adverse Events with a Pembrolizumab Biosimilar (Pembroria);Safety and Risk of Pharmacotherapy;2023-04-28
5. Nivolumab treatment in a mucosal melanoma patient with pre-existing systemic lupus erythematosus: A case report with literature review;Acta Facultatis Medicae Naissensis;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3